Organogenesis Holdings (ORGO) Asset Utilization Ratio (2017 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Asset Utilization Ratio of 0.92 for Q1 2026, down 3.19% year-over-year from 0.95 in Q1 2025, and down 9.6% quarter-over-quarter from 1.02 in Q4 2025.
Organogenesis Holdings (ORGO) Asset Utilization Ratio (2017 - 2026) Analysis & Trends
Organogenesis Holdings' Asset Utilization Ratio history runs 10 years deep, the most recent figure standing at 0.92 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 3.19% year-over-year to 0.92; the TTM figure through Mar 2026 stood at 0.92 (down 3.19% YoY), while the FY2025 annual figure was 1.03, up 2.23% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.92, down from 1.02 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 1.05 in Q1 2022, with the low at 0.92 in Q1 2026.
- The 5-year median for Asset Utilization Ratio is 0.99 (2022), against an average of 0.99.
- The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio dropped 19.74% in 2022, then climbed 8.75% in 2024.
- Organogenesis Holdings' Asset Utilization Ratio stood at 0.99 in 2022, then retreated by 5.61% to 0.94 in 2023, then rose by 8.75% to 1.02 in 2024, then fell by 0.32% to 1.02 in 2025, then retreated by 9.6% to 0.92 in 2026.
- Business Quant data shows ORGO's Asset Utilization Ratio at 0.92 in Q1 2026, 1.02 in Q4 2025, and 0.96 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Organogenesis Holdings | 239.33 Mn | 192.49 Mn | 20.08 Mn | 0.99 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.99 |
| Mar 31, 2026 | 0.92 |
| Dec 31, 2025 | 1.02 |
| Sep 30, 2025 | 0.96 |
| Jun 30, 2025 | 0.93 |
| Mar 31, 2025 | 0.95 |
| Dec 31, 2024 | 1.02 |
| Sep 30, 2024 | 1.02 |
| Jun 30, 2024 | 0.99 |
| Mar 31, 2024 | 0.95 |
| Dec 31, 2023 | 0.94 |
| Sep 30, 2023 | 0.98 |
| Jun 30, 2023 | 1.02 |
| Mar 31, 2023 | 1.03 |
| Dec 31, 2022 | 0.99 |
| Sep 30, 2022 | 1.01 |
| Jun 30, 2022 | 1.03 |
| Mar 31, 2022 | 1.05 |
| Dec 31, 2021 | 1.15 |
| Sep 30, 2021 | 1.23 |